PNC Financial Services Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.2K | Hold |
9,002
| – | – | ﹤0.01% | 3607 |
|
|
2026
Q1 | $22.2K | Sell |
9,002
-493
| -5% | -$1.04K | ﹤0.01% | 3644 |
|
|
2025
Q4 | $19.5K | Sell |
9,495
-3,220
| -25% | -$9.3K | ﹤0.01% | 3672 |
|
|
2025
Q3 | $44.1K | Hold |
12,715
| – | – | ﹤0.01% | 3277 |
|
|
2025
Q2 | $28K | Sell |
12,715
-54
| -0.4% | -$88 | ﹤0.01% | 3414 |
|
|
2025
Q1 | $14.8K | Buy |
12,769
+4,334
| +51% | +$6.38K | ﹤0.01% | 3678 |
|
|
2024
Q4 | $10.7K | Buy |
8,435
+647
| +8% | +$1.65K | ﹤0.01% | 3779 |
|
|
2024
Q3 | $26.6K | Buy |
7,788
+772
| +11% | +$3.36K | ﹤0.01% | 3380 |
|
|
2024
Q2 | $32.8K | Sell |
7,016
-23,210
| -77% | -$131K | ﹤0.01% | 3246 |
|
|
2024
Q1 | $224K | Sell |
30,226
-13
| -0% | -$108 | ﹤0.01% | 2086 |
|
|
2023
Q4 | $306K | Sell |
30,239
-425
| -1% | -$3.73K | ﹤0.01% | 1845 |
|
|
2023
Q3 | $239K | Sell |
30,664
-200
| -0.6% | -$1.72K | ﹤0.01% | 1988 |
|
|
2023
Q2 | $254K | Sell |
30,864
-72
| -0.2% | -$627 | ﹤0.01% | 2038 |
|
|
2023
Q1 | $224K | Hold |
30,936
| – | – | ﹤0.01% | 2078 |
|
|
2022
Q4 | $274K | Hold |
30,936
| – | – | ﹤0.01% | 1922 |
|
|
2022
Q3 | $379K | Buy |
30,936
+125
| +0.4% | +$1.95K | ﹤0.01% | 1681 |
|
|
2022
Q2 | $364K | Sell |
30,811
-11,000
| -26% | -$147K | ﹤0.01% | 1733 |
|
|
2022
Q1 | $795K | Buy |
41,811
+19,594
| +88% | +$364K | ﹤0.01% | 1373 |
|
|
2021
Q4 | $590K | Sell |
22,217
-10,974
| -33% | -$378K | ﹤0.01% | 1586 |
|
|
2021
Q3 | $1.36M | Sell |
33,191
-3
| -0% | -$164 | ﹤0.01% | 1045 |
|
|
2021
Q2 | $1.88M | Sell |
33,194
-461
| -1% | -$17K | ﹤0.01% | 940 |
|
|
2021
Q1 | $1.41M | Buy |
33,655
+372
| +1% | +$21.2K | ﹤0.01% | 1027 |
|
|
2020
Q4 | $2.33M | Buy |
33,283
+2,832
| +9% | +$116K | ﹤0.01% | 798 |
|
|
2020
Q3 | $854K | Buy |
30,451
+371
| +1% | +$12.1K | ﹤0.01% | 1106 |
|
|
2020
Q2 | $890K | Sell |
30,080
-14,134
| -32% | -$369K | ﹤0.01% | 1086 |
|
|
2020
Q1 | $876K | Buy |
44,214
+4,532
| +11% | +$114K | ﹤0.01% | 1027 |
|
|
2019
Q4 | $1.18M | Buy |
39,682
+800
| +2% | +$20K | ﹤0.01% | 1032 |
|
|
2019
Q3 | $884K | Sell |
38,882
-2,632
| -6% | -$65.2K | ﹤0.01% | 1312 |
|
|
2019
Q2 | $1.03M | Sell |
41,514
-88
| -0.2% | -$2.1K | ﹤0.01% | 1271 |
|
|
2019
Q1 | $1.02M | Buy |
41,602
+10,323
| +33% | +$234K | ﹤0.01% | 1284 |
|
|
2018
Q4 | $711K | Buy |
31,279
+30,177
| +2,738% | +$821K | ﹤0.01% | 1382 |
|
|
2018
Q3 | $35K | Buy |
1,102
+2
| +0.2% | +$65 | ﹤0.01% | 3207 |
|
|
2018
Q2 | $39K | Sell |
1,100
-200
| -15% | -$7.08K | ﹤0.01% | 3144 |
|
|
2018
Q1 | $43K | Buy |
1,300
+988
| +317% | +$35.2K | ﹤0.01% | 3048 |
|
|
2017
Q4 | $10K | Buy |
+312
| New | +$7.86K | ﹤0.01% | 3682 |
|
|
2016
Q3 | – | Sell |
-59
| Closed | -$1K | – | 4056 |
|
|
2016
Q2 | $1K | Buy |
+59
| New | +$1.99K | ﹤0.01% | 4340 |
|
Other funds holding EDIT
GCP
EAM
PNC Financial Services Group's EDIT Position: Q2 2026 in Review
PNC Financial Services Group held its Editas Medicine (EDIT) position steady in Q2 2026 at 9,002 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3607.
PNC Financial Services Group first reported a position in EDIT in Q2 2016 and has held it in 36 quarters since. The position peaked at $2.33M in Q4 2020. 84 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.
- PNC Financial Services Group held 9,002 shares of Editas Medicine worth $29.2K as of Q2 2026.
- PNC Financial Services Group left its Editas Medicine share count unchanged in Q2 2026.
- Editas Medicine made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3607 holding.
- PNC Financial Services Group first reported a position in Editas Medicine in Q2 2016 and has held it in 36 quarters since.
- PNC Financial Services Group's Editas Medicine position peaked at $2.33M in Q4 2020.
- 84 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.